1. Askenase PW, Hayden BJ, Gershon RK (1975) Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med 141: 697
2. Awwad M, North RJ (1988) Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden. Immunology 65: 87
3. Awwad M, North RJ (1989) Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells. Cancer Res 49: 1649
4. Bear HD (1986) Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T cells from immune and early tumorbearing host spleens. Cancer Res 46: 1805
5. Bear HD (1987) Production of tumor-specific suppressor T cell hybridomas. J Surg Res 42: 369